Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Altarac currently holds 167,572 shares of Entasis Therapeutics Holdings Inc. (ETTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Altarac has been a net seller of ETTX stock. They have purchased $0 and sold $12.0K worth of shares.
David Altarac's most recent insider trade was on Jul 11, 2022, when they sold 150,000 shares at $0.00 per share.
David Altarac serves as Executive at Entasis Therapeutics Holdings Inc. (ETTX). They have executed 7 insider transactions totaling $12.0K over their tenure at the company.
David Altarac holds the position of Executive at Entasis Therapeutics Holdings Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
David Altarac has shown a selling trading pattern, with $0 in total purchases and $12.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Altarac was on Jul 7, 2022, when they sold $38.7K worth of ETTX shares. This transaction involved 17,572 shares at $2.20 per share.
David Altarac currently owns 167,572 shares of Entasis Therapeutics Holdings Inc. (ETTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Altarac's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Altarac has 7 Form 4 filings on record as an insider at Entasis Therapeutics Holdings Inc..
Set alerts for David Altarac and 40,000+ other insiders.